AnalyzeDirect Chade AR, Krier JD, Textor SC, Lerman A, Lerman LO. Endothelin-a receptor blockade improves renal microvascular architecture and function in experimental hypercholesterolemia. J Am Soc Nephrol. December 2006;17(12):3394-3403.
Full Text – Open Access
Publication Date
December 2006
How Analyze was Used
“3-D volume images were reconstructed and analyzed with the Analyze software package.”
Keywords
Animals
Blood Pressure/physiology
Disease Models, Animal
Endothelin A Receptor Antagonists
Glomerular Filtration Rate/physiology
Hypercholesterolemia/physiopathology
Imaging, Three-Dimensional
Kidney/blood supply/metabolism
Microcirculation/physiopathology
Pyrrolidines/pharmacology
Receptor, Angiotensin, Type 1/metabolism
Renin/blood
Sus scrofa
Tomography, X-Ray Computed
Vascular Endothelial Growth Factor A/metabolism
Author Affiliation(s)
Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, MN, US. (ARC, JDK, SCT, LOL)
Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN, US. (AL, LOL)
ID# 1966
Tags: Angiotensin Receptor_Type 1/metabolism, Animal Disease Models, Animals, Blood Pressure/physiology, Endothelin A Receptor Antagonists, Glomerular Filtration Rate/physiology, Hypercholesterolemia/physiopathology, Kidney/blood supply/metabolism, Microcirculation/physiopathology, Pyrrolidines/pharmacology, Renin/blood, Sus scrofa, Three-Dimensional Imaging, Vascular Endothelial Growth Factor A/metabolism, X-Ray Computed Tomography